Microencapsulation technology utilizing collagen and gelatin for pharmaceutical applications. Enables controlled release and protection of sensitive active ingredients in medical formulations.
Manufactured by
GELITA AG
Eberbach, Germany
GELITA Presents Innovative Excipient Solutions at Compamed 2025 in Düsseldorf GELITA, a global expert in pharmaceutical gelatin and collagen peptides, showcases its latest excipient innovations at Compamed 2025 in Düsseldorf. The company highlights MEDELLAPRO® and VACCIPRO®—two excipients designed to meet the demanding needs of harmaceutical formulations and medical devices. Part of GELITAs Endotoxin Controlled Excipients (ECE) portfolio, MEDELLAPRO® (gelatin) and VACCIPRO® (collagen peptides) are ideal for applications such as vaccine stabilization, tissue engineering, implants, advanced wound care, and 3D bioprinting. Strict endotoxin control ensures product safety and supports regulatory compliance in sensitive medical applications.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
CorTec GmbH
Germany · 2 relevant products
NEOMED CO., LTD.
South Korea · 1 relevant product
Shanghai Baiyiyuan Bioengineering Co., Ltd
China · 1 relevant product
23 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →7 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 30 closest product alternatives
CorTec GmbH · Germany
Hermetic encapsulation technology for active implantable neurotechnology devices, providing reliable sealing and protection for long-term biocompatibility. Designed for neuromodulation and neural interface applications, this encapsulation solution ensures device integrity and clinical safety in implantable systems.
NEOMED CO., LTD. · South Korea
Advanced gel-based material technology for medical device applications, offering temperature regulation and adaptive support properties. Utilized in various therapeutic and protective medical devices.
Shanghai Baiyiyuan Bioengineering Co., Ltd · China
A synthetic extracellular matrix technology platform designed for tissue engineering and regenerative medicine. It features a three-dimensional reticular structure composed of collagen and extracellular matrix substances, provides excellent biocompatibility, contains long-chain amino acids that can induce cell proliferation, differentiation, migration, and aggregation, and plays an important role in tissue repair and reconstruction.
27 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products